Annual report 2023

Consolidated statement of changes in equity

January 1 – December 31

 

 

 

 

Attributable to shareholders of medmix Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2022

 

 

 

0.4

 

552.8

 

–6.5

 

–0.6

 

–12.2

 

533.9

 

 

533.9

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

11.6

 

 

 

 

 

 

 

11.6

 

 

11.6

– Cash flow hedges, net of tax

 

26

 

 

 

 

 

1.2

 

 

1.2

 

 

1.2

– Remeasurements of defined benefit plans, net of tax

 

8

 

 

 

–4.7

 

 

 

 

–4.7

 

 

–4.7

– Currency translation differences

 

 

 

 

 

 

 

 

–11.9

 

–11.9

 

 

–11.9

Other comprehensive income

 

 

 

 

 

–4.7

 

 

1.2

 

–11.9

 

–15.4

 

 

–15.4

Total comprehensive income for the period

 

 

 

 

 

6.8

 

 

1.2

 

–11.9

 

–3.9

 

 

–3.9

Contribution to the Sulzer group

 

21

 

 

 

–0.4

 

 

 

 

–0.4

 

 

–0.4

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of treasury shares to share plan participants

 

21

 

 

 

–0.1

 

0.1

 

 

 

 

 

Purchase of treasury shares

 

21

 

 

 

 

–6.1

 

 

 

–6.1

 

 

–6.1

Share-based payments

 

28

 

 

 

1.8

 

 

 

 

1.8

 

 

1.8

Dividends

 

21

 

 

 

–20.5

 

 

 

 

–20.5

 

 

–20.5

Equity as of December 31, 2022

 

21

 

0.4

 

540.3

 

–12.5

 

0.7

 

–24.1

 

504.8

 

 

504.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2023

 

 

 

0.4

 

540.3

 

–12.5

 

0.7

 

–24.1

 

504.8

 

 

504.8

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

0.3

 

 

 

 

 

 

 

0.3

 

0.4

 

0.7

– Cash flow hedges, net of tax

 

26

 

 

 

 

–1.6

 

 

–1.6

 

 

–1.6

– Remeasurements of defined benefit plans, net of tax

 

8

 

 

19.5

 

 

 

 

19.5

 

 

19.5

– Currency translation differences

 

 

 

 

–24.6

 

–24.6

 

–0.4

 

–25.0

Other comprehensive income

 

 

 

 

19.5

 

 

–1.6

 

–24.6

 

–6.7

 

–0.4

 

–7.1

Total comprehensive income for the period

 

 

 

 

19.8

 

 

–1.6

 

–24.6

 

–6.4

 

–0.0

 

–6.4

Sale of investments in subsidiaries

 

 

 

 

–2.0

 

 

 

 

–2.0

 

 

–2.0

Put option liability

 

4

 

 

–9.8

 

 

 

 

–9.8

 

 

–9.8

Contribution to the Sulzer group

 

21

 

 

–0.3

 

 

 

 

–0.3

 

 

–0.3

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition of subsidiary with non-controlling interests

 

4

 

 

 

 

 

 

 

9.0

 

9.0

Allocation of treasury shares to share plan participants

 

21

 

 

–0.4

 

0.4

 

 

 

 

 

Purchase of treasury shares

 

21

 

 

 

–3.1

 

 

 

–3.1

 

 

–3.1

Share-based payments

 

28

 

 

2.5

 

 

 

 

2.5

 

 

2.5

Dividends

 

21

 

 

–20.5

 

 

 

 

–20.5

 

 

–20.5

Equity as of December 31, 2023

 

21

 

0.4

 

529.8

 

–15.2

 

–0.9

 

–48.7

 

465.4

 

9.0

 

474.3